BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3554348)

  • 1. The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease.
    Candy JM; Perry EK; Perry RH; Court JA; Oakley AE; Edwardson JA
    Prog Brain Res; 1986; 70():105-32. PubMed ID: 3554348
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
    Whitehouse PJ
    Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
    [No Abstract]   [Full Text] [Related]  

  • 3. The functional organization of the basal forebrain cholinergic system in primates and the role of this system in Alzheimer's disease.
    Price DL; Cork LC; Struble RG; Whitehouse PJ; Kitt CA; Walker LC
    Ann N Y Acad Sci; 1985; 444():287-95. PubMed ID: 3160283
    [No Abstract]   [Full Text] [Related]  

  • 4. The cholinergic system in Alzheimer's disease and dementia with Lewy bodies: from animal models to neuropathological data.
    Liberini P
    Funct Neurol; 1997; 12(3-4):153-7. PubMed ID: 9218969
    [No Abstract]   [Full Text] [Related]  

  • 5. The cholinergic hypothesis: a historical overview, current perspective, and future directions.
    Bartus RT; Dean RL; Pontecorvo MJ; Flicker C
    Ann N Y Acad Sci; 1985; 444():332-58. PubMed ID: 2990293
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.
    Perry EK; Curtis M; Dick DJ; Candy JM; Atack JR; Bloxham CA; Blessed G; Fairbairn A; Tomlinson BE; Perry RH
    J Neurol Neurosurg Psychiatry; 1985 May; 48(5):413-21. PubMed ID: 3998751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular forms of acetylcholinesterases in Alzheimer's disease.
    Younkin SG; Goodridge B; Katz J; Lockett G; Nafziger D; Usiak MF; Younkin LH
    Fed Proc; 1986 Dec; 45(13):2982-8. PubMed ID: 2430839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cholinergic deficit in Alzheimer's disease.
    Whitehouse PJ
    J Clin Psychiatry; 1998; 59 Suppl 13():19-22. PubMed ID: 9771826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease.
    Etienne P; Robitaille Y; Wood P; Gauthier S; Nair NP; Quirion R
    Neuroscience; 1986 Dec; 19(4):1279-91. PubMed ID: 3822122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease and the new neuroscience.
    Wortis J
    Biol Psychiatry; 1983 Aug; 18(8):847-8. PubMed ID: 6137248
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholinergic controversies.
    Perry EK; Irving D; Perry RH
    Trends Neurosci; 1991 Nov; 14(11):483-4; author reply 485-6. PubMed ID: 1726763
    [No Abstract]   [Full Text] [Related]  

  • 12. The morphological basis of dementia in Parkinson's disease.
    Ball MJ
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):180-4. PubMed ID: 6713315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dementia of Parkinson's disease and Alzheimer's disease. Is there a difference?
    Stern MB; Gur RC; Saykin AJ; Hurtig HI
    J Am Geriatr Soc; 1986 Jun; 34(6):475-8. PubMed ID: 3700936
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase.
    Pearson RC; Sofroniew MV; Cuello AC; Powell TP; Eckenstein F; Esiri MM; Wilcock GK
    Brain Res; 1983 Dec; 289(1-2):375-9. PubMed ID: 6362777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.
    Rossor MN; Svendsen C; Hunt SP; Mountjoy CQ; Roth M; Iversen LL
    Neurosci Lett; 1982 Feb; 28(2):217-22. PubMed ID: 7070710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical review of the role of the cholinergic system in human memory and cognition.
    Davies P
    Ann N Y Acad Sci; 1985; 444():212-7. PubMed ID: 3860088
    [No Abstract]   [Full Text] [Related]  

  • 17. Overview of morphological changes in Parkinson's disease.
    Jellinger K
    Adv Neurol; 1987; 45():1-18. PubMed ID: 3825687
    [No Abstract]   [Full Text] [Related]  

  • 18. [Abnormalities of neurotransmitters in Alzheimer's disease. Disturbance of the acetylcholine system and nucleus basalis of Meynert].
    Arai H; Iizuka R
    Nihon Rinsho; 1988 Jul; 46(7):1491-5. PubMed ID: 3221455
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current concepts on the hypothesis of the cholinergic etiology of Alzheimer's disease ].
    Coralli MV; Zanotti E; Salsi A
    Recenti Prog Med; 1986 Sep; 77(9):436-9. PubMed ID: 3541087
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation of choline acetyltransferase activity between the nucleus basalis of Meynert and the cerebral cortex.
    Koshimura K; Kato T; Yohyama I; Nakamura S; Kameyama M
    Neurosci Res; 1987 Apr; 4(4):330-6. PubMed ID: 3601249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.